Gene · 4680
Papers1,711
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,711
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unveiling the Genomic Landscape of Escherichia coli O1:K1:H7 ST59 in Non-complicated Urinary Infections from Colombia Through Whole-Genome Sequencing. | Curr Microbiol | 2025 | 40960668 | PubTator, text mining | PubMed |
| CEACAM6 as a machine learning derived immune biomarker for predicting neoadjuvant chemotherapy response in HR+/HER2- breast cancer. | Front Immunol | 2025 | 40936892 | PubTator, text mining | PubMed |
| Expression of aberrant markers in monitoring of measurable residual disease in B-cell precursor acute lymphoblastic leukemia patients during remission-inducing therapy phase. | Front Oncol | 2025 | 40936710 | PubTator, text mining | PubMed |
| Safety of unconventional antibody-drug conjugate L-DOS47 in a phase I/II monotherapy study targeting advanced NSCLC. | Front Oncol | 2025 | 40860822 | PubTator, text mining | PubMed |
| Reconstitution of T cell-mediated immunity by umbilical cord-derived mesenchymal stem cells in ulcerative colitis. | Clin Transl Med | 2025 | 40842289 | PubTator, text mining | PubMed |
| Novel cancer-associated secretory cells and IL-1β+ macrophages as key players in early lung adenocarcinoma progression in female never-smokers. | Clin Transl Med | 2025 | 40824728 | PubTator, text mining | PubMed |
| The expression of CD109 in B-cell acute lymphoblastic leukemia and its potential as a promising marker for minimal residual disease (MRD) detection. | Clin Exp Med | 2025 | 40810756 | PubTator, text mining | PubMed |
| Editorial: Recent advances and new biomarkers in ulcerative colitis, volume II. | Front Med (Lausanne) | 2025 | 40747088 | PubTator, text mining | PubMed |
| 2024 CSACI Annual Scientific Meeting Book of Abstracts. | Allergy Asthma Clin Immunol | 2025 | 40745660 | PubTator, text mining | PubMed |
| Programmable protein ligation on cell surfaces. | Nature | 2025 | 40739351 | PubTator, text mining | PubMed |
| Integrative RNA-sequencing analysis of COPD-related genes in association with individual PM2.5 exposure. | Environ Res | 2025 | 40684981 | PubTator, text mining | PubMed |
| The PTPN2 rs1893217 IBD risk allele increases susceptibility to AIEC invasion by a JAK-STAT-CEACAM6 axis. | Gut Microbes | 2025 | 40624731 | PubTator, text mining | PubMed |
| Proteomic Landscape of Colorectal Cancer Derived Liver Metastasis Reveals Three Distinct Phenotypes With Specific Signaling and Enhanced Survival. | Mol Cell Proteomics | 2025 | 40617497 | PubTator, text mining | PubMed |
| HPV6-Induced Gene Expression Signature in Recurrent Respiratory Papillomatosis. | Laryngoscope | 2025 | 40481740 | PubTator, text mining | PubMed |
| A Phase I Study of the Anti-CEACAM6 Antibody Tinurilimab (BAY 1834942) in Patients with Advanced Solid Tumors. | Target Oncol | 2025 | 40465170 | PubTator, text mining | PubMed |
| TRIM29 upregulation contributes to chemoresistance in triple negative breast cancer via modulating S100P-β-catenin axis. | Cell Commun Signal | 2025 | 40420099 | PubTator, text mining | PubMed |
| Hypoxia and Hypoxia-Reoxygenation Potentiate Helicobacter pylori Infection and Gastric Epithelial Cell Proliferation. | Cancer Med | 2025 | 40325849 | PubTator, text mining | PubMed |
| DSCT: a novel deep-learning framework for rapid and accurate spatial transcriptomic cell typing. | Natl Sci Rev | 2025 | 40313458 | PubTator, text mining | PubMed |
| Study of immunological and inflammatory gene response in Indian cohort of COVID- 19 patients by NanoString technology. | Immunol Res | 2025 | 40299133 | PubTator, text mining | PubMed |
| InSituCor: exploring spatially correlated genes conditional on the cell type landscape. | Genome Biol | 2025 | 40275395 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4680/papers?page=5